Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II–Induced Aortic Aneurysm and Atherosclerosis
Smriti M. Krishna(Baker Heart and Diabetes Institute), Jonathan Golledge(Townsville Hospital), C. M. Rush(Lawrence Livermore National Laboratory), Yutang Wang(Federation University), Vianne Nsengiyumva(Lawrence Livermore National Laboratory), Erik Biroš(Lawrence Livermore National Laboratory), Roby J. Jose(Lawrence Livermore National Laboratory), J. Lindeman(Leiden University Medical Center), Jeffrey M. Craig(Murdoch Children's Research Institute), Sai Wang Seto(The University of Western Australia), Jiaze Li(Lawrence Livermore National Laboratory), Susan K. Morton(Lawrence Livermore National Laboratory), Gabriela G. Loots(Institute for Musculoskeletal Health)
Cited by 174
Related Papers
Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms
|European Journal of Vascular and Endovascular Surgery|2024|996
Diet and depression: exploring the biological mechanisms of action
|Molecular Psychiatry|2020|634
Kynurenine is an endothelium-derived relaxing factor produced during inflammation
|Nature Medicine|2010|450
Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis
|Stroke|2015|279
Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China
|CHEST Journal|2014|270